Announcement from the company. (edited) "Screening and enrollment of patients is on-going at all active trial sites. 58 patients have now been enrolled into the study. More than half the enrolled patients have completed the dosing phase of the trial...." .."The Company now expects that all the remaining patients will be enrolled and the study completed in time for trial results to be reported in 1Q’08, which is slightly later than previous guidance of year end ‘07".
ANP Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
